BNSCX | VSGAX | BNSCX / VSGAX | |
Total Expense Ratio | 1.24 | 0.07 | 1,771% |
Annual Report Gross Expense Ratio | 1.55 | 0.07 | 2,214% |
Fund Existence | 26 years | 14 years | - |
Gain YTD | -13.444 | -3.883 | 346% |
Front Load | 6% | N/A | - |
Min. Initial Investment | 1000 | 3000 | 33% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 98.9M | 35B | 0% |
Annual Yield % from dividends | 0.00 | 0.57 | - |
Returns for 1 year | -9.45 | 8.12 | -116% |
Returns for 3 years | -5.36 | 23.00 | -23% |
Returns for 5 years | -17.75 | 34.02 | -52% |
Returns for 10 years | -31.81 | 105.72 | -30% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
BIB | 46.75 | 1.54 | +3.41% |
ProShares Ultra Nasdaq Biotechnology | |||
DGS | 54.01 | 0.18 | +0.33% |
WisdomTree Emerging Markets SmCp Div ETF | |||
RNWZ | 23.65 | 0.06 | +0.23% |
TrueShares Eagle Glbl Rnwbls Engy IncETF | |||
DFCA | 49.01 | -0.14 | -0.27% |
Dimensional California Municipal Bd ETF | |||
PZC | 6.19 | -0.02 | -0.32% |
PIMCO California Municipal Income Fund III |